U.S. FDA Approves Broad New Labels For NEXLETOL® And NEXLIZET® To Prevent Heart Attacks And Cardiovascular Procedures In Both Primary And Secondary Pr... menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
(Family Features) Heart disease is the nation’s leading cause of death for men and women, according to the Centers for Disease Control and Prevention, but many people aren’t aware they
Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR – Get Free Report) have received an average recommendation of “Hold” from the seven analysts that are covering the stock, MarketBeat.com reports. Four investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 year price objective […]
Esperion Therapeutics, Inc. (NASDAQ:ESPR – Free Report) – Investment analysts at Northland Capmk issued their Q1 2024 earnings per share (EPS) estimates for shares of Esperion Therapeutics in a research note issued on Wednesday, February 28th. Northland Capmk analyst C. Byrnes forecasts that the biopharmaceutical company will post earnings per share of ($0.25) for the […]
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript February 27, 2024 Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.53. Esperion Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and […]